During the past decade, Espaco Medico Coimbra conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Espaco Medico Coimbra" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Association for Innovation and Biomedical Research on Light and Image" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "José Cunha-Vaz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Espaco Medico Coimbra" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator, "European Vision Institute Clinical Research Network" with 2 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Espaco Medico Coimbra" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "High Risk Proliferative Diabetic Retinopathy" (2 trials), "Macular Edema" (2 trials) and "Branch Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Espaco Medico Coimbra" in a lesser frequency.

Most popular intervention types in "Espaco Medico Coimbra" are "Drug" (11 trials), "Procedure" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Intravitreous injection of ranibizumab" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Espaco Medico Coimbra" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Espaco Medico Coimbra". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Espaco Medico Coimbra, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Espaco Medico Coimbra, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".